Cargando…
Detection of EGFR-SEPT14 fusion in cell-free DNA of a patient with advanced gastric cancer: A case report
BACKGROUND: Gastric cancer is the fifth most diagnosed cancer worldwide and the third most common cause of cancer-related death. In recent decades, increasing application of next-generation sequencing has enabled detection of molecular aberrations, including fusions. In cases where tissue is difficu...
Autores principales: | Kim, Boyeon, Kim, Yoonjung, Park, Inho, Cho, Jae Yong, Lee, Kyung-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058666/ https://www.ncbi.nlm.nih.gov/pubmed/33969073 http://dx.doi.org/10.12998/wjcc.v9.i12.2884 |
Ejemplares similares
-
Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer
por: Kim, Boyeon, et al.
Publicado: (2024) -
Selecting short length nucleic acids localized in exosomes improves plasma EGFR mutation detection in NSCLC patients
por: Kim, Yoonjung, et al.
Publicado: (2019) -
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
por: Wang, Weidong, et al.
Publicado: (2023) -
Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer
por: Kim, Boyeon, et al.
Publicado: (2022) -
A Comparative Study for Detection of EGFR Mutations in Plasma Cell-Free DNA in Korean Clinical Diagnostic Laboratories
por: Kim, Yoonjung, et al.
Publicado: (2018)